Chapter 2 73 70. M Courtois, et al, Ageing and hair cycles, British J Dermatology, 132(1), 86-93 (1995). 71. LC Sperling, DS Mezebish, Hair diseases, Med Clin North America, 8(5), 1155-69 (1998). 72. M Kunz, et al, Seasonality of hair shedding in healthy women complaining of hair loss, Dermatology, 219(2), 105-10 (2009). 73. N Hunt, S McHale, The psychological impact of alopecia, BMJ, 331(7522), 951-3 (2005). 74. LH Su, TH Chen, Association of androgenetic alopecia with smoking and its prevalence among Asian men: A community-based survey, Arch Dermatol, 143(11), 1401-6 (2007). 75. OT Norwood, Male pattern baldness: Classification and incidence, South Med J, 68(11), 1359-65 (1975). 76. MP Birch, AG Messenger, Genetic factors predispose to balding and non-balding in men, Eur J Dermatol, 11(4), 309-14 (2001). 77. OT Norwood, Incidence of female androgenetic alopecia (female pattern alopecia), Dermatol Surg, 27(1), 53-4 (2001). 78. TL Wang, et al, Prevalence of androgenetic alopecia in China: A community-based study in six cities, Br J Dermatol, 162(4), 843-7 (2010). 79. JH Paik, et al, The prevalence and types of androgenetic alopecia in Korean men and women, Br J Dermatol, 145(1), 95-9 (2001). 80. W Chen, et al, Hair loss in elderly women, Eur J Dermatol, 20(2), 145-51 (2010). 81. JT Headington, Telogen effluvium: New concepts and review, Arch Dermatol, 129(3), 356-63 (1993). 82. J Shapiro, et al, Practical management of hair loss, Canadian Family Physician, 46, 1469- 77 (2000). 83. DA Whiting, Chronic telogen effluvium: increased scalp hair shedding in middle-aged women, J Am Acad Dermatol, 35(6), 899-906 (1996). 84. R Sinclair, Chronic telogen effluvium: A study of 5 patients over 7 years, J Am Acad Dermatol, 52(2 Suppl 1), 12-6 (2005). 85. RM Trueb, Chemotherapy-induced alopecia, Semin Cutan Med Surg, 28(1), 11-4 (2009). 86. KH Safavi, et al, Third incidence of alopecia areata in Olmsted County, Minnesota: 1975 through 1989, Mayo Clin Proc, 70(7), 628-33 (1995). 87. A Gilhar, RS Kalish, Alopecia areata: a tissue specific autoimmune disease of the hair follicle, Autoimmun Rev, 5(1), 64-9 (2006). 88. N Barahmani, et al, History of atopy or autoimmunity increases risk of alopecia areata, J Am Acad Dermatol, 61(4), 581-91 (2009). 89. A Alkhalifah, et al, Alopecia areata update: Part II, Treatment, J Am Acad Dermatol, 62(2), 191-202 (2010). 90. DE Sah, J Koo, VH Price, Trichotillomania, Dermatol Ther, 21(1), 13-21 (2008). 91. DC Duke, et al, Trichotillomania: A current review, Clin Psychol Rev, 30(2), 181-93 (2010). 92. CM Aaronson, Etiologic factors in traction alopecia, South Med J, 62(2), 185-6 (1969). 93. A Tosti, et al, Hair casts are a dermoscopic clue for the diagnosis of traction alopecia, Br J Dermatol, 163(6), 1353-5 (2010). 94. JY Lee, ML Hsu, Tinea capitis in adults in southern Taiwan, Int J Dermatol, 30(8), 572-5 (1991). 95. LC Sperling, SE Cowper, The histopathology of primary cicatricial alopecia, Semin Cutan Med Surg, 25(1), 41-50 (2006). 96. N Somani, WF Bergfeld, Cicatricial alopecia: Classification and histopathology, Dermatol Ther, 21(4), 221-37 (2008). 97. MJ Harries, R Paus, The pathogenesis of primary cicatricial alopecias, Am J Pathol, 177(5), 2152-62 (2010). 98. SE Millar, et al, WNT signaling in the control of hair growth and structure, Dev Biol, 207(1), 133-49 (1999).